Max Healthcare Institute Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹2,143Cr
- +12.2% YoY
- +3.6% QoQ
- Net profit
- ₹342Cr
- +7.2% YoY
- +13.6% QoQ
- Margin
- 28%
- +1 pp YoY
- +2 pp QoQ
Guidance rank: #7 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Phased commissioning of 20% additional brownfield capacity across Mohali, Nanavati, and Max Smart hospitals, with beds becoming operational over next 2-3 months, driving revenue growth. Max Healthcare has added over 20% additional brownfield capacity recently, with phased commissioning completing in the next 2-3 months, expected to significantly enhance operating leverage as beds ramp up.
From Max Healthcare Institute Ltd's Q4 FY26 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- Phased commissioning of 20% additional brownfield capacity across Mohali, Nanavati, and Max Smart hospitals, with beds becoming operational over next 2-3 months, driving revenue growth.
- Expected addition of 10% capacity with commissioning of 500-bed greenfield hospital in Gurgaon during FY27, contributing to revenue expansion.
- Ongoing expansion projects such as Max Lucknow (from 426 to 570 beds in next 2 quarters), Max Gurgaon (500 beds, commissioning expected this year), Nagpur (100 beds by FY28), and Zirakpur Mohali (400 beds by FY28) will support future volume growth.
- Oncology share expected to stabilize at 21-22%, with other specialties compensating for revenue; overall ARPOB growth expected at 6-7% if no OBD growth.
2 more points from Max Healthcare Institute Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Board approved INR 1,400 crore investment to build a 700-bed greenfield hospital at Shaheed Path, Lucknow, expected over about 3 years.
- Phased capacity expansion ongoing:
- Gomti Nagar Lucknow increasing capacity from current 426 beds to 570 beds within two quarters.
- Plans to add another 200-300 beds at Gomti Nagar over the next decade, potentially reaching ~2,000 beds.
- Upcoming hospital expansions include:
- 500 beds at Sector 56 Gurgaon, commissioning targeted by end of current year.
- 100 beds at Max Nagpur, expected commissioning by FY28.
- 400 beds at Zirakpur, Mohali, on schedule for FY28.
- 260 beds at Max Dwarka, expected completion in 24 months.
- 200 beds at Max Vaishali, awaiting building plan approvals.
- 400 beds at Max Patparganj, commissioning expected by FY29.
2 more points from Max Healthcare Institute Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company is undertaking multiple expansion projects, with phased commissioning planned over the next 2-3 years.
- Key ongoing projects:
- Max Lucknow capacity increasing from 426 to 570 beds over next 2 quarters.
- 500 beds at Sector 56 Gurgaon, expected commissioning by end of FY '27.
- 100 beds at Max Nagpur, commissioning expected by FY '28.
- 400 beds at Zirakpur, Mohali, commissioning expected by FY '28.
- 260 beds at Max Dwarka, building plans underway; 24 months to complete.
- 200 beds at Max Vaishali pending building plan approvals; 24 months post approval to complete.
- 400 beds at Max Patparganj with construction started, commissioning expected by FY '29.
2 more points from Max Healthcare Institute Ltd's call on order book
Create a free account to keep reading this call
Max Healthcare Institute Ltd — Quarterly revenue & net profit
Max Healthcare Institute Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 2,143 | 1,910 | +12.2% | 2,068 | +3.6% |
| Operating profit (EBITDA) | 606 | 512 | +18.4% | 538 | +12.6% |
| Operating margin | 28% | 27% | +1 pp | 26% | +2 pp |
| Profit before tax | 465 | 402 | +15.7% | 365 | +27.4% |
| Net profit (PAT) | 342 | 319 | +7.2% | 301 | +13.6% |
| EPS (₹) | 3.52 | 3.28 | +7.3% | 3.09 | +13.9% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Max Healthcare's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Sciences (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- KMC Speciality (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Max Healthcare Institute Ltd Q4 FY26 results?
Phased commissioning of 20% additional brownfield capacity across Mohali, Nanavati, and Max Smart hospitals, with beds becoming operational over next 2-3 months, driving revenue growth. Max Healthcare has added over 20% additional brownfield capacity recently, with phased commissioning completing in the next 2-3 months, expected to significantly enhance operating leverage as beds ramp up.
What is Max Healthcare Institute Ltd share price analysis?
Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 68.2 with a market cap of ₹102,129 Cr. Investors should review the full earnings analysis for detailed insights.
Is Max Healthcare Institute Ltd planning capital expenditure?
Board approved INR 1,400 crore investment to build a 700-bed greenfield hospital at Shaheed Path, Lucknow, expected over about 3 years.
Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
